Beall H D, Mulcahy R T, Siegel D, Traver R D, Gibson N W, Ross D
School of Pharmacy, University of Colorado Health Sciences Center, Denver 80262.
Cancer Res. 1994 Jun 15;54(12):3196-201.
The metabolisms of two standard electron acceptors and a series of bioreductive antitumor compounds by purified rat and human DT-diaphorases (DTD) were compared. DTD was purified from rat liver cytosol and from Escherichia coli in which rat liver or human lung tumor DTD complementary DNA was expressed. Km and kcat values for menadione and 2,6-dichlorophenolindophenol reduction were similar for the three enzyme preparations except that rat E. coli DTD had 2-3-fold higher kcat values for both menadione and 2,6-dichlorophenolindophenol and a 2-3-fold higher Km for menadione than either rat liver or human E. coli DTD. Reduction of the antitumor compounds was 1.9-4.9 times faster with rat E. coli DTD than with human E. coli DTD. The antitumor compounds were reduced in the following order by rat E. coli DTD: 2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone > streptonigrin > mitomycin A > diaziquone > mitomycin C (MC) > 5-(aziridin-1-yl)-2,4-dinitrobenzamide. The order was the same for human E. coli DTD with one exception; diaziquone was reduced slightly faster than mitomycin A. Metabolism of doxorubicin could not be detected using rat or human E. coli DTD. MC-induced DNA cross-linking was also more efficient using rat E. coli DTD relative to human E. coli DTD. Metabolism of MC by rat and human E. coli DTD was also compared under aerobic and hypoxic conditions. Rates of reduction of MC and metabolite formation were similar under aerobic and hypoxic conditions, and the toxicity of MC to DTD-rich HT-29 cells was also similar in aerobic and hypoxic conditions. In contrast, the toxicity of MC to DTD-deficient BE cells was potentiated markedly under hypoxia. These data show that although small catalytic differences between rat and human E. coli DTD can be observed, compounds such as 2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone and streptonigrin are still excellent substrates for the human enzyme and may be useful in the therapy of tumors high in DTD activity. In addition, metabolism of MC by rat and human E. coli DTD was similar in aerobic and hypoxic conditions; in agreement with these data, cytotoxicity of MC to a DTD-rich cell line was oxygen independent. Increased MC cytotoxicity under hypoxia appears to be mediated by enzymes other than DTD.
比较了纯化的大鼠和人DT-黄递酶(DTD)对两种标准电子受体及一系列生物还原抗肿瘤化合物的代谢情况。DTD是从大鼠肝细胞溶胶以及表达大鼠肝或人肺肿瘤DTD互补DNA的大肠杆菌中纯化得到的。三种酶制剂对甲萘醌和2,6-二氯酚靛酚还原反应的米氏常数(Km)和催化常数(kcat)值相似,只是大鼠大肠杆菌DTD对甲萘醌和2,6-二氯酚靛酚的kcat值比大鼠肝或人大肠杆菌DTD高2至3倍,且对甲萘醌的Km值比大鼠肝或人大肠杆菌DTD高2至3倍。大鼠大肠杆菌DTD对抗肿瘤化合物的还原速度比人大肠杆菌DTD快1.9至4.9倍。大鼠大肠杆菌DTD对抗肿瘤化合物的还原顺序为:2,5-二甲基-3,6-二氮丙啶基-1,4-苯醌>链黑菌素>丝裂霉素A>重氮醌>丝裂霉素C(MC)>5-(氮丙啶-1-基)-2,4-二硝基苯甲酰胺。人大肠杆菌DTD的还原顺序与之相同,只是有一个例外;重氮醌的还原速度比丝裂霉素A略快。使用大鼠或人大肠杆菌DTD均未检测到阿霉素的代谢情况。相对于人大肠杆菌DTD,使用大鼠大肠杆菌DTD时,MC诱导的DNA交联也更有效。还比较了大鼠和人大肠杆菌DTD在有氧和缺氧条件下对MC的代谢情况。有氧和缺氧条件下MC的还原速率和代谢产物形成速率相似,且MC对富含DTD的HT-29细胞的毒性在有氧和缺氧条件下也相似。相比之下,缺氧时MC对缺乏DTD的BE细胞的毒性明显增强。这些数据表明,尽管大鼠和人大肠杆菌DTD之间存在微小的催化差异,但2,5-二甲基-3,6-二氮丙啶基-1,4-苯醌和链黑菌素等化合物仍是人酶的优良底物,可能对DTD活性高的肿瘤治疗有用。此外,大鼠和人大肠杆菌DTD在有氧和缺氧条件下对MC的代谢相似;与这些数据一致,MC对富含DTD的细胞系的细胞毒性与氧气无关。缺氧时MC细胞毒性的增加似乎是由DTD以外的酶介导的。